October 18, 2016 — At the 2016 annual meeting of the Radiological Society of North America (RSNA 2016), Siemens Healthineers will showcase an expanded version of xSPECT Quant, its established single-photon emission computed tomography (SPECT) quantification technology. xSPECT Quant enables users of the company’s Symbia Intevo SPECT/CT system to perform automated, accurate and reproducible quantification of not just Technetium-99m — the most common isotope in SPECT imaging — but also, for the first time, Iodine-123, Lutetium-177 and Indium-111. This extends the use of advanced SPECT quantification from general nuclear medicine and bone studies to indications including neurological disorders, neuroendocrine tumors, neuroblastoma and metastatic prostate cancer.
For more information: www.healthcare.siemens.com
July 30, 2024 
